TP53 and cancer: Given the potential of using mutant p53 protein as a therapeutic target in many cancer types, and the longstanding debate of whether GOF activities exist, there is a critical need to study mutant p53 GOF activities in models of epithelial malignancies controlled for the confounding effects of exogenous protein expression and chromosomal alterations that occur following p53 LOF.